Why Is Armata Pharma Stock Gaining Monday?
Armata Pharmaceuticals Inc ARMP
$4.54
▼ -5.02%
($-0.24)
🗓️ Earnings Next Week
Open
$4.76
Prev Close
$4.78
Day Range
$4.52 – $4.84
52W Range
$2.36 – $16.34
Market Cap
$166.67M
Beta
1.37
EPS (TTM)
$-7.76
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 1994-05-20 |
| Shares Out. | 36,710,000 |
| Website | armatapharma.com/ ↗ |
| Phone | 13106652928 |
| Employees | 61 |
| Revenue | $789,000 |
| Gross Profit | $789,000 |
| Net Income | -$115.3M |
| Free Cash Flow | -$24.5M |
| Total Assets | $69.8M |
| Total Liabilities | $381.4M |
| Equity | -$311.6M |
About Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Armata Pharmaceuticals Inc is a publicly traded company under the ticker symbol ARMP on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)